+Search query
-Structure paper
| Title | Structural and immunogenetic signatures guide CD4-mimetic HIV vaccine development. |
|---|---|
| Journal, issue, pages | Cell Rep, Vol. 45, Issue 4, Page 117180, Year 2026 |
| Publish date | Apr 15, 2026 |
Authors | Daniel L V Bader / Claudia T Flynn / Oleksandr Kalyuzhniy / Gabriel Ozorowski / Martin M Corcoran / Alison Burns / Pilar Altman / Romy Rouzeau / Troy Sincomb / Alessia Liguori / Monica L Fernández-Quintero / Johannes R Loeffler / Jonathan L Torres / Hannah L Turner / Erik Georgeson / Amelia Zhou / Hannah Voic / Sue Goo / Lara Shahin / Iszac Burton / Mengyu Wu / Robyn L Stanfield / Saman Eskandarzadeh / Danny Lu / Nushin Alavi / Nicole Phelps / Ryan Tingle / Katherine McKenney / John Youhanna / Sonya Amirzehni / Torben Schiffner / Jon M Steichen / Dennis R Burton / Ian A Wilson / Gunilla B Karlsson Hedestam / Elise Landais / Jeong Hyun Lee / Devin Sok / Christopher A Cottrell / Andrew B Ward / William R Schief / ![]() |
| PubMed Abstract | HIV vaccine strategies include aims to elicit broadly neutralizing antibodies (bnAbs) targeting the CD4-binding site, that are derived from immunoglobulin heavy-chain variable genes 1-2 (V1-2) and 1- ...HIV vaccine strategies include aims to elicit broadly neutralizing antibodies (bnAbs) targeting the CD4-binding site, that are derived from immunoglobulin heavy-chain variable genes 1-2 (V1-2) and 1-46 (V1-46). Here, we present an integrated analysis of V1-46 bnAbs, including in vitro functional studies, cryo-electron microscopy structures of two V1-46 bnAbs (1-23 and 9-71) complexed with envelope trimers, and comprehensive structural and immunogenetic analyses, to help guide vaccine design. We show that V1-46-derived bnAbs use diverse light-chain variable (V/V) genes and LCDR3 lengths commonly found in human antibody repertoires, which generate unique LCDR3 signatures that influence both the antibody paratope and approach angle. We identify three V1-46 bnAb classes, 1B2530 (V1-47), CH235 (V3-15), and 561 (V3-20), with the 561 class further subdivided into types I and II. Our findings indicate that V1-46 priming immunogens should be tailored to each bnAb class, with 561-class bnAbs presenting optimal targets for germline-targeting vaccine design. |
External links | Cell Rep / PubMed:41996239 |
| Methods | EM (single particle) |
| Resolution | 3.1 - 3.5 Å |
| Structure data | EMDB-71677, PDB-9pit: EMDB-71678, PDB-9piv: |
| Chemicals | ![]() ChemComp-NAG: |
| Source |
|
Keywords | VIRAL PROTEIN / HIV-1 / SOSIP / human / broadly neutralizing antibody / Fab |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links





human immunodeficiency virus 1
homo sapiens (human)
Keywords